International Co-ordination of Drug Trials. Rheumatological Research, and the Fight Against Rheumatic Diseases in Switzerland: Papers and Discussions Held at the 30th Anniversary of the European League Against Rheumatism in Zürich, 28th - 30th April 1977 |
Contents
INTERNATIONAL COORDINATION OF DRUG | 9 |
Inflammatory Mediators | 28 |
Clinical Measurements | 41 |
Copyright | |
3 other sections not shown
Common terms and phrases
abnormalities activity adverse reactions age groups alkaline phosphatase analgesic analysis ankylosing spondylitis anti-inflammatory drugs anti-rheumatic drugs antibodies arthrosis articular chondrocalcinosis aspirin assessment backache Basle bone Böni CALIFORN cathepsin cathepsin D cells centres chondrocalcinosis chronic clinical trials controlled correlation criteria diclofenac disorders dosage double blind duration efficacy enzymes EULAR evaluation factors Fallet G. H. Fehr functional Huskisson ibuprofen important indomethacin inflammation inflammatory injection investigators joint laboratory League against Rheumatism levamisole long-term trial measurement technician ment metacarpal index method morning stiffness Müller multicentre trial neutral protease number of patients observations osteoarthrosis osteoporosis penicillamine physician placebo possible posture problem Prof prophylaxis prostaglandins protocol psychic radiological rheu Rheum rheumatic diseases rheumatoid arthritis rheumatology Scand side-effects significant standard statistical symptoms synovial fluid Table test-persons tests therapeutic therapy tion tissue toxicity treatment ulna UNIVERSIT unwanted effects Vischer T. L. visual analogue scale X-ray Zurich